StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Price on monday

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Apr 03, 2021 4:16pm

156 Views

Post# 32934204

RE:RE:RE:RE:RE:RE:Price on monday

Dude... SZLS closed at $1.58 on Wednesday.
Since then, the positives are:
- Outstanding financials with the promise of better to come
- Major, international expansion and acquisition. A wider stance in the market.
- A cash-free deal, freeing up our reserves for more aggressive moves in the future.
The negatives are:
- Boohoo, the financials were announced before a weekend, giving investors time to think about their decision, so the market will be harder to manipulate down... *tear
All signs point to a huge gap up.
$1.21 is already in the past... unless you want to sell ME your shares at that price, hehehehe!
Have a great-sun-filled weekend, all, and a very Happy Monday!!